美股異動|美國鋼鐵升超4.3% 公司與新日鐵就拜登否決交易提起訴訟
美國鋼鐵(X.US)升4.36%,報31.8美元。消息面上,新日鐵和美國鋼鐵週一聯合聲明指,向美國哥倫比亞特區巡迴上訴法院提起訴訟,質疑總統拜登否決該兩公司合併交易的決定,並稱美國外國投資委員會小組未能考慮該交易以國家安全為由。此外,該兩公司在美國賓州西區地方法院對競爭對手美國鋼鐵製造商克里夫蘭克利夫斯公司及其行政總裁Lourenco Goncalves和美國鋼鐵工人工會主席David McCall提起訴訟。兩公司表示,真誠地與各方進行接觸,以強調該交易將增強而不是威脅美國的國家安全。(格隆匯)

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.